Together, these results clearly demonstrate that curcumin-treatment induces alterations of metabolic activities characterizing CML cells and strongly related to the activity of HIF-1α pathway, known to have a critical role in in the pathogenesis of CML [4, 6, 7]. The gene discussed is HIF1A; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.